- Home
- DDD vs KRRO Comparison
DDD vs KRRO Comparison
Compare DDD & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- KRRO
- Stock Information
- Founded
- DDD 1986
- KRRO 2014
- Country
- DDD United States
- KRRO United States
- Employees
- DDD N/A
- KRRO N/A
- Industry
- DDD Computer peripheral equipment
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- DDD Technology
- KRRO Health Care
- Exchange
- DDD Nasdaq
- KRRO Nasdaq
- Market Cap
- DDD 268.5M
- KRRO 209.6M
- IPO Year
- DDD N/A
- KRRO 2019
- Fundamental
- Price
- DDD $2.37
- KRRO $15.56
- Analyst Decision
- DDD Hold
- KRRO Strong Buy
- Analyst Count
- DDD 3
- KRRO 7
- Target Price
- DDD $3.50
- KRRO $90.67
- AVG Volume (30 Days)
- DDD 2.3M
- KRRO 102.4K
- Earning Date
- DDD 05-12-2025
- KRRO 05-07-2025
- Dividend Yield
- DDD N/A
- KRRO N/A
- EPS Growth
- DDD N/A
- KRRO N/A
- EPS
- DDD N/A
- KRRO N/A
- Revenue
- DDD $440,121,000.00
- KRRO $4,821,000.00
- Revenue This Year
- DDD N/A
- KRRO N/A
- Revenue Next Year
- DDD $5.15
- KRRO $55.56
- P/E Ratio
- DDD N/A
- KRRO N/A
- Revenue Growth
- DDD N/A
- KRRO N/A
- 52 Week Low
- DDD $1.71
- KRRO $11.13
- 52 Week High
- DDD $5.00
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- DDD 62.44
- KRRO 45.62
- Support Level
- DDD $1.92
- KRRO $13.40
- Resistance Level
- DDD $2.06
- KRRO $22.15
- Average True Range (ATR)
- DDD 0.12
- KRRO 2.47
- MACD
- DDD 0.08
- KRRO 0.07
- Stochastic Oscillator
- DDD 91.54
- KRRO 24.69
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.